| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| TLXTelix Pharmaceuticals Limited | 2.49B | 7.43 | 53.07 | 55.85% | 3.98% | 15.63% | 0.36% | 1.02 |
| EXELExelixis, Inc. | 12.18B | 45.44 | 25.82 | 18.49% | 29.63% | 31.37% | 5.2% | 0.09 |
| BBOTBridgeBio Oncology Therapeutics Inc. | 919.87M | 11.50 | 25 | -25.73% | ||||
| INBXInhibrx Biosciences, Inc. | 1.04B | 71.80 | 0.62 | -88.89% | -110.78% | -421.09% | 0.06 | |
| NUVBNuvation Bio Inc. | 2.1B | 6.14 | -2.91 | -8.13% | -66.74% | 0.02 | ||
| RLAYRelay Therapeutics, Inc. | 1.32B | 7.63 | -3.23 | -60.83% | -26.71% | -48.97% | 0.06 | |
| ORICORIC Pharmaceuticals, Inc. | 1.12B | 11.52 | -6.30 | -33.24% | 0.01 | |||
| ZLABZai Lab Limited | 2.09B | 18.82 | -7.24 | 49.59% | -46.83% | -27.21% | 0.18 |
| Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 6.67M | 7.58M | 14.32M | 42.98M | 25.9M | 53.6M | 131.4M | 78.5M | 263.4M |
| Revenue Growth % | - | 0.14% | 0.89% | 2% | -0.4% | 1.07% | 1.45% | -0.4% | 2.36% |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - |
| Gross Profit | 6.67M | 7.58M | 14.32M | 42.98M | 25.9M | 53.6M | 131.4M | 78.5M | 263.4M |
| Gross Margin % | 1% | 1% | 1% | 1% | 1% | 1% | 1% | 1% | 1% |
| Gross Profit Growth % | - | 0.14% | 0.89% | 2% | -0.4% | 1.07% | 1.45% | -0.4% | 2.36% |
| Operating Expenses | 23.14M | 32.34M | 58.13M | 94.5M | 146.7M | 242M | 394.6M | 480M | 513.6M |
| OpEx % of Revenue | 3.47% | 4.27% | 4.06% | 2.2% | 5.66% | 4.51% | 3% | 6.11% | 1.95% |
| Selling, General & Admin | 3.2M | 3.55M | 12.93M | 27.31M | 38.3M | 61.6M | 79.6M | 100.3M | 165.4M |
| SG&A % of Revenue | 0.48% | 0.47% | 0.9% | 0.64% | 1.48% | 1.15% | 0.61% | 1.28% | 0.63% |
| Research & Development | 19.94M | 28.79M | 45.19M | 67.19M | 108.4M | 180.4M | 315M | 379.7M | 348.2M |
| R&D % of Revenue | 2.99% | 3.8% | 3.16% | 1.56% | 4.19% | 3.37% | 2.4% | 4.84% | 1.32% |
| Other Operating Expenses | 0 | 0 | 102.73K | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -16.47M | -24.76M | -43.8M | -51.52M | -120.8M | -188.4M | -263.2M | -401.5M | -250.2M |
| Operating Margin % | -2.47% | -3.27% | -3.06% | -1.2% | -4.66% | -3.51% | -2% | -5.11% | -0.95% |
| Operating Income Growth % | - | -0.5% | -0.77% | -0.18% | -1.34% | -0.56% | -0.4% | -0.53% | 0.38% |
| EBITDA | -16.03M | -24.41M | -43.1M | -49.27M | -117.6M | -182.4M | -255M | -394.8M | -243.6M |
| EBITDA Margin % | -2.4% | -3.22% | -3.01% | -1.15% | -4.54% | -3.4% | -1.94% | -5.03% | -0.92% |
| EBITDA Growth % | - | -0.52% | -0.77% | -0.14% | -1.39% | -0.55% | -0.4% | -0.55% | 0.38% |
| D&A (Non-Cash Add-back) | 436.33K | 347.39K | 706K | 2.25M | 3.2M | 6M | 8.2M | 6.7M | 6.6M |
| EBIT | -14.37M | -24M | -41.42M | -70.21M | -120.8M | -188.4M | -263.2M | -401.5M | -250.2M |
| Net Interest Income | 360.37K | 151.03K | 2.41M | 4.5M | 3.52M | 1.7M | 12M | 38.8M | 54.8M |
| Interest Income | 427.77K | 201.39K | 2.47M | 4.6M | 3.59M | 1.8M | 12M | 38.8M | 54.8M |
| Interest Expense | 67.4K | 50.36K | 57.44K | 100K | 65K | 100K | 0 | 0 | 0 |
| Other Income/Expense | 2.03M | 711.06K | 2.32M | -18.79M | 1.5M | -2.6M | 1.6M | 35.1M | 51.9M |
| Pretax Income | -14.44M | -24.05M | -41.48M | -70.3M | -119.3M | -191M | -261.6M | -366.4M | -198.3M |
| Pretax Margin % | -2.16% | -3.17% | -2.9% | -1.64% | -4.61% | -3.56% | -1.99% | -4.67% | -0.75% |
| Income Tax | -87.41K | 0 | 0 | 0 | 0 | 0 | 20.9M | 900K | 600K |
| Effective Tax Rate % | 0.99% | 1% | 1% | 1% | 1% | 1% | 1.08% | 1% | 1% |
| Net Income | -14.35M | -24.05M | -41.48M | -70.29M | -119.3M | -191M | -282.5M | -367.3M | -198.9M |
| Net Margin % | -2.15% | -3.17% | -2.9% | -1.64% | -4.61% | -3.56% | -2.15% | -4.68% | -0.76% |
| Net Income Growth % | - | -0.68% | -0.72% | -0.69% | -0.7% | -0.6% | -0.48% | -0.3% | 0.46% |
| Net Income (Continuing) | -14.35M | -24.05M | -41.48M | -70.3M | -119.3M | -191M | -282.5M | -367.3M | -198.9M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -7.56 | -1.38 | -1.31 | -1.89 | -3.02 | -3.82 | -5.31 | -6.62 | -2.77 |
| EPS Growth % | - | 0.82% | 0.05% | -0.44% | -0.6% | -0.26% | -0.39% | -0.25% | 0.58% |
| EPS (Basic) | -7.56 | -1.38 | -1.31 | -1.89 | -3.02 | -3.82 | -5.31 | -6.62 | -2.77 |
| Diluted Shares Outstanding | 1.9M | 20.73M | 31.63M | 32.93M | 39.53M | 50M | 53.2M | 55.5M | 71.9M |
| Basic Shares Outstanding | 1.9M | 20.73M | 31.63M | 32.93M | 39.53M | 50M | 53.2M | 55.5M | 71.9M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |
| Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 37.28M | 65.53M | 195.68M | 290.88M | 703.1M | 1.55B | 1.24B | 1.28B | 1.07B |
| Cash & Short-Term Investments | 35.56M | 39.17M | 187.83M | 280.87M | 688.6M | 1.5B | 1.21B | 1.26B | 1.04B |
| Cash Only | 5.09M | 30.91M | 3.19M | 9.21M | 588.4M | 108.3M | 81.3M | 311.7M | 100.5M |
| Short-Term Investments | 30.47M | 8.26M | 184.64M | 271.66M | 100.2M | 1.39B | 1.12B | 949.3M | 938.9M |
| Accounts Receivable | 1.41M | 26.04M | 5.03M | 6.28M | 8.4M | 25.7M | 8M | 7.2M | 13.7M |
| Days Sales Outstanding | 77.18 | 1.25K | 128.22 | 53.34 | 118.38 | 175.01 | 22.22 | 33.48 | 18.98 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 | 4.5M | 26.9M | 12M | 14.2M |
| Total Non-Current Assets | 654.61K | 1.32M | 3.6M | 10.76M | 14.3M | 29.1M | 28.6M | 24.4M | 24.1M |
| Property, Plant & Equipment | 633.85K | 1.3M | 3.58M | 10.73M | 14.3M | 16.6M | 17.8M | 14M | 16M |
| Fixed Asset Turnover | 10.52x | 5.83x | 4.00x | 4.00x | 1.81x | 3.23x | 7.38x | 5.61x | 16.46x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 20.76K | 20.76K | 20.76K | 26.76K | 0 | 12.5M | 10.8M | 10.4M | 8.1M |
| Total Assets | 37.94M | 66.85M | 199.28M | 301.64M | 717.4M | 1.58B | 1.27B | 1.3B | 1.09B |
| Asset Turnover | 0.18x | 0.11x | 0.07x | 0.14x | 0.04x | 0.03x | 0.10x | 0.06x | 0.24x |
| Asset Growth % | - | 0.76% | 1.98% | 0.51% | 1.38% | 1.2% | -0.2% | 0.03% | -0.16% |
| Total Current Liabilities | 10.03M | 17.85M | 22.98M | 32.81M | 49.2M | 261.7M | 295.1M | 257.1M | 229.8M |
| Accounts Payable | 1.57M | 596.53K | 2.76M | 4.56M | 7.1M | 31.3M | 5.7M | 17.8M | 13.4M |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 141.21K | 159.26K | 154.46K | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Liabilities | 0 | 0 | 0 | 5.81M | 9M | 12.4M | 18.7M | 48M | 0 |
| Current Ratio | 3.72x | 3.67x | 8.52x | 8.86x | 14.29x | 5.93x | 4.20x | 4.98x | 4.64x |
| Quick Ratio | 3.72x | 3.67x | 8.52x | 8.86x | 14.29x | 5.93x | 4.20x | 4.98x | 4.64x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 3.87M | 48.75M | 39.63M | 42.14M | 26M | 538.2M | 408.8M | 387.5M | 299.9M |
| Long-Term Debt | 312.57K | 151.12K | 2M | 2M | 2M | 1M | 1M | 800K | 600K |
| Capital Lease Obligations | 0 | 0 | 0 | 1.71M | 1.1M | 2.9M | 2.7M | 500K | 7.3M |
| Deferred Tax Liabilities | -56.85M | -61.43M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 56.76K | 50.89K | 150K | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 13.91M | 66.6M | 62.61M | 74.96M | 75.2M | 799.9M | 703.9M | 644.6M | 529.7M |
| Total Debt | 453.79K | 310.39K | 2.15M | 4.39M | 4.1M | 5M | 5.5M | 3.2M | 9.7M |
| Net Debt | -4.63M | -30.6M | -1.04M | -4.82M | -584.3M | -103.3M | -75.8M | -308.5M | -90.8M |
| Debt / Equity | 0.02x | 1.26x | 0.02x | 0.02x | 0.01x | 0.01x | 0.01x | 0.00x | 0.02x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -244.34x | -491.69x | -762.57x | -515.25x | -1858.46x | -1884.00x | - | - | - |
| Total Equity | 24.03M | 245.87K | 136.67M | 226.69M | 642.2M | 781.7M | 564.9M | 660M | 561.7M |
| Equity Growth % | - | -0.99% | 554.85% | 0.66% | 1.83% | 0.22% | -0.28% | 0.17% | -0.15% |
| Book Value per Share | 12.66 | 0.01 | 4.32 | 6.88 | 16.24 | 15.63 | 10.62 | 11.89 | 7.81 |
| Total Shareholders' Equity | 24.03M | 245.87K | 136.67M | 226.69M | 642.2M | 781.7M | 564.9M | 660M | 561.7M |
| Common Stock | 947.54K | 1.19M | 31.24K | 38.46K | 0 | 0 | 100K | 100K | 100K |
| Retained Earnings | -33.8M | -62.42M | -302.26M | -372.56M | -491.9M | -682.9M | -965.4M | -1.33B | -1.53B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -28.68K | -9.75K | -217.72K | 107.58K | 600K | -4.6M | -19.2M | -3.1M | 1M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -19.4M | 5.11M | -16.12M | -40.63M | -89.76M | 559.4M | -273.5M | -347.8M | -259.3M |
| Operating CF Margin % | -2.91% | 0.67% | -1.13% | -0.95% | -3.47% | 10.44% | -2.08% | -4.43% | -0.98% |
| Operating CF Growth % | - | 1.26% | -4.15% | -1.52% | -1.21% | 7.23% | -1.49% | -0.27% | 0.25% |
| Net Income | -14.35M | -24.05M | -41.48M | -70.29M | -119.33M | -191M | -282.5M | -367.3M | -198.9M |
| Depreciation & Amortization | 436.33K | 347.39K | 706K | 2.25M | 4.02M | 6M | 8.2M | 6.7M | 6.6M |
| Stock-Based Compensation | 525.59K | 245.05K | 11.63M | 20.07M | 30.2M | 57.1M | 75.5M | 71.6M | 88.2M |
| Deferred Taxes | -1.01M | -5.87K | 193.78K | 0 | -395.07K | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 556.42K | 362.07K | 266.03K | 169.17K | 1.69M | 9M | 7.9M | -14.4M | -14.6M |
| Working Capital Changes | -5.56M | 28.21M | 12.57M | 7.17M | -5.94M | 678.3M | -82.6M | -44.4M | -140.6M |
| Change in Receivables | -578.93K | -25M | 22.22M | 2.78M | -1M | -30.2M | 14M | 800K | -5.7M |
| Change in Inventory | 0 | 2.26M | -3.26M | -2.07M | 6.34M | 0 | 0 | 0 | 0 |
| Change in Payables | 1.2M | -969.48K | 2M | 1.61M | 2.04M | 27.9M | 20.2M | 17.3M | -21.2M |
| Cash from Investing | -20.11M | 20.87M | -179.67M | -93.1M | 164.25M | -1.31B | 242.8M | 203.5M | 34.7M |
| Capital Expenditures | -306.67K | -1.01M | -2.83M | -6.24M | -6.45M | -4.7M | -6.8M | -2.9M | -1.8M |
| CapEx % of Revenue | 0.05% | 0.13% | 0.2% | 0.15% | 0.25% | 0.09% | 0.05% | 0.04% | 0.01% |
| Acquisitions | - | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - | - |
| Other Investing | -50K | 21.88M | -176.83M | -86.8M | 395.07M | 0 | -400K | 0 | 0 |
| Cash from Financing | -149.74K | -161.36K | 168.06M | 139.74M | 504.67M | 278.6M | 4.7M | 374.7M | 7.9M |
| Debt Issued (Net) | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - | - |
| Other Financing | 0 | 0 | -3.35M | 0 | -20.93M | 14M | 0 | 0 | 0 |
| Net Change in Cash | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | -19.71M | 4.1M | -18.95M | -46.87M | -96.2M | 554.7M | -280.3M | -350.7M | -261.1M |
| FCF Margin % | -2.96% | 0.54% | -1.32% | -1.09% | -3.71% | 10.35% | -2.13% | -4.47% | -0.99% |
| FCF Growth % | - | 1.21% | -5.62% | -1.47% | -1.05% | 6.77% | -1.51% | -0.25% | 0.26% |
| FCF per Share | -10.39 | 0.20 | -0.60 | -1.42 | -2.43 | 11.09 | -5.27 | -6.32 | -3.63 |
| FCF Conversion (FCF/Net Income) | 1.35x | -0.21x | 0.39x | 0.58x | 0.75x | -2.93x | 0.97x | 0.95x | 1.30x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 100K | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 11.1M | 11.1M | 2.3M |
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -59.72% | -198.12% | -60.59% | -38.69% | -27.46% | -26.83% | -41.96% | -59.97% | -32.56% |
| Return on Invested Capital (ROIC) | -63.68% | - | -62.41% | -21.62% | -64.77% | -38.38% | -33.82% | -71.65% | -45.63% |
| Gross Margin | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% | 100% |
| Net Margin | -215.18% | -317.32% | -289.59% | -163.56% | -460.62% | -356.34% | -214.99% | -467.9% | -75.51% |
| Debt / Equity | 0.02x | 1.26x | 0.02x | 0.02x | 0.01x | 0.01x | 0.01x | 0.00x | 0.02x |
| Interest Coverage | -244.34x | -491.69x | -762.57x | -515.25x | -1858.46x | -1884.00x | - | - | - |
| FCF Conversion | 1.35x | -0.21x | 0.39x | 0.58x | 0.75x | -2.93x | 0.97x | 0.95x | 1.30x |
| Revenue Growth | - | 13.64% | 89% | 200.03% | -39.73% | 106.95% | 145.15% | -40.26% | 235.54% |
| 2024 | |
|---|---|
| License | 130M |
| License Growth | - |
Arvinas, Inc. (ARVN) reported $312.3M in revenue for fiscal year 2024. This represents a 4583% increase from $6.7M in 2016.
Arvinas, Inc. (ARVN) grew revenue by 235.5% over the past year. This is strong growth.
Arvinas, Inc. (ARVN) reported a net loss of $58.5M for fiscal year 2024.
Arvinas, Inc. (ARVN) has a return on equity (ROE) of -32.6%. Negative ROE indicates the company is unprofitable.
Arvinas, Inc. (ARVN) had negative free cash flow of $329.5M in fiscal year 2024, likely due to heavy capital investments.